More than 430,000 bottles of painkillers under the Excedrin brand have been recalled due to a manufacturing defect that may have left holes in the bottom of Excedrin bottles.
GlaxoSmithKline (GSK), Excedrin’s manufacturer, announced the recall Wednesday for many of its aspirin and acetaminophen-based, over-the-counter products sold nationwide between March 2018 and September 2020.
The products — sold under the names Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets — violated the Poison Prevention Packaging Act, which mandates childproof packaging for over-the-counter and prescription drugs, among other possibly hazardous household products.
A full list of products can be found on the GSK website.
The Excedrin bottles were supplied by a third-party manufacturer, per a statement from GSK, and were sold nationwide and online. No injuries or incidents have been reported.
Excedrin bottles without holes in its bottoms can be kept and used as directed, per a notice posted on the Consumer Product Safety Commission website. Those with holes, however, can be returned to GlaxoSmithKline for a full refund.
The company issued a “stop sale” alert in October, which was not a full recall.
Follow Joshua Bote on Twitter: @joshua_bote.
